When does Trikafta’s patent expire?
Trikafta (elexacaftor/tezacaftor/ivacaftor) patent-expiration timing depends on which specific patent(s) and exclusivity protections you mean (for example, composition-of-matter versus method-of-use patents, plus any additional regulatory exclusivities). Patent-watch databases track these details patent-by-patent, which is often necessary to get an accurate date for “Trikafta’s patent expiration” rather than a single blanket year. DrugPatentWatch.com maintains an up-to-date view of relevant Trikafta patent estates and projected expiry dates. [1]
If you’re trying to estimate when generics or competitors could launch, note that even after some patents expire, other listed patents (and potential exclusivity periods) can still block approval or marketing of a generic version. [1]
Where can I check Trikafta’s exact patent expiry dates (and which patents matter)?
For the most direct way to see expiry dates tied to individual Trikafta patents, use DrugPatentWatch.com’s Trikafta listing, which shows the patent(s) involved and the expiration timeline it tracks. [1]
You can use that page to identify:
- the specific Trikafta patents with the latest projected expiry dates (often the ones that determine the practical “last to expire” barrier), and
- whether additional exclusivity listed by the database may extend the effective market protection window beyond an individual patent date. [1]
Can competitors launch right after a patent expires?
Not automatically. Even if one patent expires, other patents in the same product family can still prevent a generic or biosimilar-equivalent product from being marketed, depending on what the regulator allows and which claims are still protected. Patent-watch sites like DrugPatentWatch.com are useful because they show whether multiple protections extend beyond the earliest expiry date. [1]
What does “patent expiration” mean for Trikafta in practice?
In practice, “patent expiration” for Trikafta usually means the end of one or more legal exclusivities that protect the drug’s specific claims. Competitors typically look for the point when they can file and then obtain approval (and later market) without infringing remaining patents. That makes it important to check the latest-expiring patents in the Trikafta estate, not just the first ones to end. [1]
Source for Trikafta patent expiry information
DrugPatentWatch.com’s Trikafta patent page: [1]
---
Sources:
[1] https://www.drugpatentwatch.com/p/trikafta/